Predictive Toxicogenomics Space Score for Gene Expression Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for predicting human toxicity of chemical compounds are inefficient due to the lack of mechanistic interpretation of genomic changes and reliance on loose thresholds, leading to non-specific and predictive inferences in chemical risk assessment.
Innovation Solution
A method using probabilistic component modeling to derive a Predictive Toxicogenomics Space (PTGS) score, which identifies specific gene components activated by toxic compounds and calculates a toxicity prediction based on differential gene expression, enhancing the prediction of compound toxicity in industries like pharmaceuticals and agrochemicals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional QSAR approaches and structure-based read-across are used for toxicity prediction, then the assessment process is simple and fast, but the prediction accuracy and mechanistic interpretation are insufficient
Solution Approach 1:
The patent segments the complex genomic data into functional modules through Adverse Outcome Pathways (AOPs). Each AOP represents a distinct causal chain from molecular initiating events to adverse outcomes, allowing the system to process and interpret genomic changes in manageable, mechanistically-meaningful units rather than as an undifferentiated mass of data
Solution Approach 2:
The patent introduces AOPs as intermediary constructs that bridge the gap between raw genomic data and toxicity predictions. These AOPs serve as mechanistic mediators that translate complex gene expression patterns into interpretable causal pathways, enabling both accurate prediction and mechanistic understanding without requiring direct analysis of the entire genomic dataset
2Loss of information
If genome-wide profiling technologies are used to generate comprehensive data, then more information is available for analysis, but the data interpretation becomes more difficult and less specific
Solution Approach 1:
The patent divides the comprehensive genomic dataset into discrete AOP-specific gene sets. Each AOP encompasses a specific subset of genes relevant to particular toxicological mechanisms, allowing researchers to analyze only the pertinent genomic information for each toxicological question rather than attempting to interpret the entire genome-wide dataset simultaneously
Solution Approach 2:
The patent applies different analytical approaches and thresholds to different AOPs based on their specific biological characteristics and data quality. Each AOP can be optimized independently with appropriate statistical parameters, making the interpretation process more specific and less prone to general errors that would affect a unified analysis approach
3Productivity
If loose TTC thresholds and structure-based read-across are used, then the assessment process is efficient, but the predictions are not sufficiently specific or predictive
Solution Approach 1:
The patent implements a dynamic assessment framework where the stringency and approach of toxicity evaluation can be adjusted based on the available data quality, the specific chemical being assessed, and the regulatory context. The system can operate in different modes ranging from rapid screening using simplified approaches to more rigorous evaluation using comprehensive AOP-based analysis, allowing efficiency to be maintained while enabling higher specificity when needed
Solution Approach 2:
The patent changes the fundamental parameters of toxicity assessment by moving from structure-based read-across and fixed TTC thresholds to expression-based AOP analysis. This parameter change enables the system to achieve both efficiency and specificity by using gene expression data that directly reflect the biological activity of chemicals within the AOP framework, providing more predictive power than structural analogies
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A novel method to predict toxicity and dose-dependent effects of an agent based on transcriptomic data analysis, by determining a predictive toxicogenomics space (PTGS) score. The PTGS score helps to predict and model the toxicity of compounds typically consisting of chemicals, pharmaceuticals, cosmetics and agrochemicals. The invention further comprises methods of deriving the PTGS score, as well as computer programs to calculate PTGS scores.